Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

NCT06059638 is registered in ClinicalTrials.gov with Orchestra BioMed, Inc as lead sponsor.

NCT NCT06059638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06059638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Lead sponsor
Orchestra BioMed, Inc
Phase
Not applicable
Overall status
Recruiting
Start date
December 27, 2023
Completion date
August 31, 2029
Enrollment
316 (estimated)
Sites
131

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, hypertension, essential, hypertension, systolic